# EDGAR Filing Document

**Accession Number:** 0001379006
**File Stem:** 0001104659-26-074774
**Filing Date:** 2026-6
**Character Count:** 2424
**Document Hash:** db650fb3cd1e0dcf92e1b8457c59ed59
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-074774.hdr.sgml**: 20260617

**ACCESSION NUMBER**: 0001104659-26-074774

**CONFORMED SUBMISSION TYPE**: DEL AM

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260617

**DATE AS OF CHANGE**: 20260616

**EFFECTIVENESS DATE**: 20260617

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NANOVIRICIDES, INC.
- **CENTRAL INDEX KEY:** 0001379006
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 760674577
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** DEL AM
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-296550
- **FILM NUMBER:** 261096307

**BUSINESS ADDRESS:**
- **STREET 1:** 1 CONTROLS DRIVE
- **CITY:** SHELTON
- **STATE:** CT
- **ZIP:** 06484
- **BUSINESS PHONE:** (203) 668-5580

**MAIL ADDRESS:**
- **STREET 1:** 1 CONTROLS DRIVE
- **CITY:** SHELTON
- **STATE:** CT
- **ZIP:** 06484

![](tm2618128d1_delamimg001.jpg)

June 16, 2026

**<u>Via EDGAR</u>**

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Re: NanoViricides, Inc <br> *Registration Statement on Form S-3* <br> *(File No. 333-296550) filed on June 15, 2026*

To Whom It May Concern:

Reference is made to the Registration Statement on Form S-3 (File No. 333-296550) filed by NanoViricides, Inc. (the "Issuer") on June 15, 2026 (the "Registration Statement").

Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the "Act"), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the facing page of the Registration Statement:

"**The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the SEC, acting pursuant to said Section 8(a) may determine."**

Should you have any questions regarding the Registration Statement, please feel free to contact Peter Campitiello, counsel to the Issuer at (732) 395-4517.

Very truly yours,

/s/ Anil Diwan

Chairman, President

NanoViricides, Inc.

cc: Peter Campitiello, Esq.